NORDIC BIOTECH HOLDING ApS: Financial statements 2019
CVR: 26409683
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NORDIC BIOTECH HOLDING ApS (CVR 26409683) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -697,462 and a net result of DKK -687,745 compared with DKK -291,582 the year before. Equity in the 2019 report amounted to DKK -787,839.
- Gross Profit
- DKK -697,462
- Profit/Loss
- DKK -687,745
- Equity
- DKK -787,839
- Total Assets
- DKK 124,893
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -697K | -688K | -788K | - |
| 2018 | - | -169K | -292K | -100K | - |
| 2017 | - | 130K | 1.1M | 191K | - |
| 2016 | - | -36K | -82K | -872K | - |
| 2015 | - | -88K | -165K | -790K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NORDIC BIOTECH HOLDING ApS has published its annual report for 2018. Gross profit came to DKK -169,214, and the net result was DKK -291,582.
About NORDIC BIOTECH HOLDING ApS
NORDIC BIOTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SN BIOTECH HOLDING ApS. The management consists of Torsten Bjørn. The company is owned by FINANSMANAGEMENT ApS. The company has 1 employee (2012). In 2025, the company reported a gross profit of DKK -39,555 and a net result of DKK -7,860 compared with DKK -39,278 the year before. Equity in the 2025 report amounted to DKK 139,260.